CSF2 and chronic obstructive pulmonary disease: Importantly, in human disease, GM-CSF expression is increased in sputum, bronchoalveolar lavage (BAL) and bronchial biopsies in asthma.12–17 In contrast, in COPD there is a lack of direct evidence of increased GM-CSF expression in airway secretions or biopsy tissue.